Addition of docetaxel to the cyclophosphamide/thiotepa/carboplatin regimen for autologous stem cell transplantation: A dose-escalation study of docetaxel for breast cancer.

被引：0
|
作者：
Kato, K [1 ]
Ohno, Y [1 ]
Miyoshi, T [1 ]
Mitsuyama, S [1 ]
Ohkubo, H [1 ]
机构：
[1] Kitakyushu Municipal Med Ctr, Fukuoka, Japan
来源：
BLOOD | 1998年 / 92卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
4579
引用
收藏
页码：367B / 367B
页数：1
相关论文
共 50 条
  • [1] Dose escalation of paclitaxel in combination with cyclophosphamide, thiotepa and carboplatin with stem cell rescue
    Yubero, A
    Majordomo, JI
    Cajal, R
    Iniguez, C
    Larrode, P
    Herraez, J
    Escudero, P
    Saenz, A
    Tres, A
    EUROPEAN JOURNAL OF CANCER, 1997, 33 : 408 - 408
  • [2] No evidence of ototoxicity after high-dose chemotherapy with cyclophosphamide, carboplatin and thiotepa followed by stem cell transplantation in patients with breast cancer.
    Garner, G
    Harkness, K
    Britt, G
    Jillella, A
    BLOOD, 1998, 92 (10) : 274A - 274A
  • [3] Erlotinib in combination with capecitabine and docetaxel in patients with metastatic breast cancer: A dose-escalation study
    Twelves, Chris
    Trigo, Jose M.
    Jones, Rob
    De Rosa, Flavio
    Rakhit, Ashok
    Fettner, Scott
    Wright, Tonya
    Baselga, Jose
    EUROPEAN JOURNAL OF CANCER, 2008, 44 (03) : 419 - 426
  • [4] A dose-escalation study of pemetrexed and docetaxel in non-small-cell lung cancer
    Kotsakis, Athanasios
    Agelaki, Sophia
    Vardakis, Nikolaos
    Stathopoulos, George
    Vamvakas, Lambros
    Kalykaki, Antonia
    Kentepozidis, Nikolaos
    Kontopodis, Emmanouel
    Sfakiotaki, Georgia
    Mavroudis, Dimitris
    Georgoulias, Vassilis
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2011, 68 (02) : 415 - 422
  • [5] A dose-escalation study of pemetrexed and docetaxel in non-small-cell lung cancer
    Athanasios Kotsakis
    Sophia Agelaki
    Nikolaos Vardakis
    George Stathopoulos
    Lambros Vamvakas
    Antonia Kalykaki
    Nikolaos Kentepozidis
    Emmanouel Kontopodis
    Georgia Sfakiotaki
    Dimitris Mavroudis
    Vassilis Georgoulias
    Cancer Chemotherapy and Pharmacology, 2011, 68 : 415 - 422
  • [6] DOSE-ESCALATION OF MITOXANTRONE GIVEN WITH THIOTEPA AND AUTOLOGOUS BONE-MARROW TRANSPLANTATION FOR METASTATIC BREAST-CANCER
    BOWERS, C
    ADKINS, D
    DUNPHY, F
    HARRISON, B
    LEMAISTRE, CF
    SPITZER, G
    BONE MARROW TRANSPLANTATION, 1993, 12 (05) : 525 - 530
  • [7] Ototoxicity after high-dose chemotherapy with cyclophosphamide, thiotepa and carboplatin followed by stem cell transplantation in patients with breast cancer
    Jillella, AP
    Britt, GW
    Litaker, MS
    Kallab, AM
    Harkness, K
    Garner, GD
    MEDICAL ONCOLOGY, 2000, 17 (04) : 287 - 292
  • [8] ototoxicity after high-dose chemotherapy with cyclophosphamide, thiotepa and carboplatin followed by stem cell transplantation in patients with breast cancer
    AP Jillella
    GW Britt
    MS Litaker
    AM Kallab
    K Harkness
    GD Garner
    Medical Oncology, 2000, 17 : 287 - 292
  • [9] Front-line treatment of metastatic breast cancer with docetaxel and epirubicin: A multicenter dose-escalation study
    Kouroussis, C
    Xydakis, E
    Potamianou, A
    Giannakakis, T
    Kakolyris, S
    Agelaki, S
    Sara, E
    Malamos, N
    Alexopoulos, A
    Mavroudis, D
    Samonis, G
    Papadouris, S
    Georgoulias, V
    Panagos, G
    ANNALS OF ONCOLOGY, 1999, 10 (05) : 547 - 552
  • [10] Dose-escalation study of docetaxel in combination with mitoxantrone as first-line treatment in patients with metastatic breast cancer
    Kouroussis, C
    Androulakis, N
    Kakolyris, S
    Souglakos, J
    Kotsakis, T
    Mavroudis, D
    Katsogridakis, K
    Vardakis, N
    Hatzidaki, D
    Samonis, G
    Vlachonikolis, J
    Georgoulias, V
    JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (03) : 862 - 869
12345